INVO Fertility, Inc. filed an 8-K to furnish an investor presentation for the H.C. Wainwright 28th Annual Global Investment Conference scheduled for September 14-16, 2026. The filing also updates progress on a capital raise under an Any Market Purchase Agreement with Alumni Capital LP. Since the registration statement became effective, the company has sold 2,094,395 shares of common stock to the investor for approximately $3,591,000 at an average price of $1.71 per share. The agreement provides a commitment amount of up to $15 million, potentially expandable to $50 million. INVO Fertility, Inc. operates in the fertility healthcare industry, providing assisted reproductive technology services and related products.
